A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

NCT05077137 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Tetanus Diptheria Vaccine
BIOLOGICAL: Polio Boost Immunization

Sponsor

Duke University